North China Pharmaceutical Company.Ltd

¥4.78As of Sun 8 Nov 2026, 12:00 UTC
SSE:600812Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (2.83%)
Div yield 0.73%
ROE 2.17%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.25
PE TTM 90.82
TSR TTM (19.69%)
Mkt cap ¥8.201B
ROIC 1.92%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥5.95
24.42%
(23.61%)
Hold 8|7|6|7|8
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.06
0.06
0.06
0.07
12.73%
7.39%
(0.16%)
7.93%
Revenue¥M
767.2
803.4
810.4
848.2
7.78%
13.84%
11.91%
12.21%
Peers (US$1.229B)
Cap (US$)
PE
1.208B
35.03x
1.175B
23.26x
Capital
TTM
5Y
10Y
Leveragex
1.446
0.177
0.148
EBIT/Intx
2.080
0.518
0.426
Own earn%
(367.41)
12.07
24.31
Sh yield%
38.78
44.18
42.94
Owners
Insiders/Inst%
0.93
81.80
Short interest%
2.86
SBC / revenue%
1.53
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
21–28
$1 testx
0.1
Incr. ROIC%
6